Fundraising Fox
/People
Sign in

Samarth Kulkarni

Chief Executive Officer and Chairman of the Board at CRISPR

United States

Find your path to Samarth

1,388 people in our graph can introduce you to Samarth.

Sign up to see every warm intro you have to Samarth

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Samarth. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

About

Samarth Kulkarni has served as Chief Executive Officer of CRISPR Therapeutics since 2017, having joined the company in 2015 as Chief Business Officer and subsequently serving as President and Chief Business Officer. Before CRISPR Therapeutics, he was a Partner at McKinsey & Company, where he co-led the biotech practice within the firm's Pharmaceutical and Medical Products practice. He holds a Ph.D. in Bioengineering and Nanotechnology from the University of Washington and a B.Tech. from the Indian Institute of Technology, and currently serves on the boards of Centessa Pharmaceuticals, Black Diamond Therapeutics, and Repare Therapeutics.

Experience

  1. CRISPR TherapeuticsChief Executive Officercurrent2017 — presentGreater Boston Area
  2. CRISPR TherapeuticsPresident2017Greater Boston Area
  3. CRISPR TherapeuticsChief Business Officer2015 — 2017Cambridge, Massachussetts
  4. Centessa PharmaceuticalsBoard Membercurrent2021 — present
  5. Black Diamond TherapeuticsBoard Membercurrent2019 — present
  6. Repare TherapeuticsBoard Membercurrent2019 — present
  7. McKinsey & CompanyPrincipal (Partner)2013 — 2015San Francisco Bay Area
  8. McKinsey & CompanyAssociate Principal2006 — 2013
  9. University of WashingtonResearch Scientist2000 — 2006

Skills & more

Biotechnology50Medical Devices31Nanotechnology19R&D10Personalized medicineHardware Diagnostics7Personalized Medicine8Commercialization9Pharmaceutical Industry28Lifesciences15Biomedical Engineering1Clinical Development3
+10 moreTechnology TransferBiochemistryStrategyCompetitive AnalysisCorporate DevelopmentCross-functional Team LeadershipVenture CapitalStart-upsMarket EntryProduct Management

From Samarth's professional profile.

Frequently asked questions

Who is Samarth Kulkarni?
Samarth Kulkarni has served as Chief Executive Officer of CRISPR Therapeutics since 2017, having joined the company in 2015 as Chief Business Officer and subsequently serving as President and Chief Business Officer. Before CRISPR Therapeutics, he was a Partner at McKinsey & Company, where he co-led the biotech practice within the firm's Pharmaceutical and Medical Products practice. He holds a Ph.D. in Bioengineering and Nanotechnology from the University of Washington and a B.Tech. from the Indian Institute of Technology, and currently serves on the boards of Centessa Pharmaceuticals, Black Diamond Therapeutics, and Repare Therapeutics.
Where did Samarth Kulkarni go to school?
Samarth Kulkarni studied at Indian Institute of Technology, Kharagpur (B.Tech, Biotechnology & Biochemical Engg); University of Washington (Doctor of Philosophy - PhD, Bioengineering and Nanotechnology).

Founder mafias

Same school

Shared employers

Also worked at Repare Therapeutics1

Jerel DavisManaging Director at Versant Ventures